This content is from: Patents
Delaware jury awards Merck biggest-ever patent award of $2.54bn
A Delaware jury has ordered Gilead Sciences to pay $2.54 billion in damages to Merck for infringing a patent related to hepatitis C treatment. It is the largest-ever patent damages award
Get Free Access to read more …
To read the full article, activate your free trial.
Get Free Access- Unlimited articles for one week
- No commitments; no payment details required
- Featuring IP strategy, copyright, patents, trademark and more!
Are you a Managing IP subscriber? Simply login here.